Estimating costs of diabetes complications in people <65 years in the U.S. using panel data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Estimating costs of diabetes complications in people <65 years in the U.S. using panel data

Published:2020-12 Issue:12 Volume:34 Page:107735
ISSN:1056-8727
Container-title:Journal of Diabetes and its Complications
language:en
Short-container-title:Journal of Diabetes and its Complications

Author:

Yang Wenya,Cintina Inna,Hoerger Thomas,Neuwahl Simon J.,Shao Hui,Laxy Michael,Zhang Ping

Funder

RTI International

Centers for Disease Control and Prevention

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference23 articles.

1. Microvascular and macrovascular complications of diabetes;Fowler;Clin. Diabetes,2008

2. Economic costs of diabetes in the U.S. in 2017, American Diabetes Association;Yang;Diabetes Care,2018

3. Lifetime costs of complications resulting from Type 2 diabetes in the U.S.;Caro;Diabetes Care,2002

4. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications;Zhuo;Am J Prev Med,2013

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous glucose monitoring for self-management of diabetes in people living with type 2 diabetes mellitus on basal insulin therapy: A microsimulation model and cost-effectiveness analysis from a US perspective with relevance to Medicaid;Journal of Managed Care & Specialty Pharmacy;2024-09

2. Use of continuous glucose monitoring when initiating glucagon‐like peptide‐1 receptor agonist therapy in insulin‐treated diabetes;Diabetes, Obesity and Metabolism;2024-08-28

3. Evaluating usability of and satisfaction with mHealth app in rural and remote areas—Germany GIZ collaboration in Bosnia-Herzegovina to optimize type 1 diabetes care;Frontiers in Digital Health;2024-06-17

4. Direct Medical Costs and Medication Use Trends in Patients Having Type 2 Diabetes with Chronic Kidney Disease in Beijing, China in 2016–2018;2024-02-13

5. Tirzepatide 10 and 15 mg vs semaglutide 2.0 mg: A long-term cost-effectiveness analysis in patients with type 2 diabetes in the United States;Journal of Managed Care & Specialty Pharmacy;2024-02-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3